20/20 Biolabs, Inc. (AIDX) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001139685 · SEC filings checked Oct 17, 2026

    Next report
    Not yet known
    Fewer than three past results filings to estimate from.
    Last close
    $0.26
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    —
    Needs four consecutive reported quarters.

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 17, 2026$730,571$-1.5M$-0.26Filing
    Mar 31, 2026May 20, 2026$353,375$-2.2M$-0.28Filing
    Jun 30, 2025—$535,060$-840,933$-0.17—
    Mar 31, 2025—$553,820$-764,577$-0.16—

    What would 20/20 Biolabs, Inc. have to report for its valuation to change?

    Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.